Lazzaro Medical

Thrilled to be a part of the incredible energy at #LSIUSA25 and share our vision for giving real people, real hope with the innovation of our co-founder Richard Lazzaro, MD FACS. Excited to push forward to help patients with TBM breathe easily, again. #HealthCareInnovation #SurgicalTech #MedTech #tracheobronchomalacia

Our President Dawn Bitz and Co-Founder Robert Israel in the house at Dana Point for #LSIUSA25. Dawn will be presenting today on Lazzaro Medical’s progress towards transforming the treatment of #Tracheobronchomalacia. Come join us! #medicaldevice #medtech

At last year's #LSI, our president, Dawn Bitz, posed a powerful question:?What if you were one of the 40 million patients struggling to breathe from respiratory issues??Now, imagine being among the approx. 8 million patients battling TBM or Tracheobronchomalacia in the U.S. alone—a debilitating disease that can devastate quality of life and, in severe cases, become life-threatening. This year at #LSI2025, we invite you to meet our team and discover how Lazzaro Medical is progressing to transform the treatment of this disease--and how you can join us to be part of the solution. #medicaldevice #healthtech

Did you know that?Tracheobronchomalacia (TBM)?is sometimes categorized as a?rare disease? In the US, a rare disease is defined as one that affects fewer than?200,000 people—yet TBM likely impacts nearly?8 million patients nationwide! TBM isn’t rare—it’s?rarely diagnosed.?Misclassification leads to?delayed recognition, misdiagnosis, and limited treatment options, leaving millions without the care they need to improve their quality of life. At?Lazzaro Medical, we’re committed to changing that. This #RareDiseaseDay, let’s raise awareness and redefine what’s possible for TBM patients.?Because a condition that affects millions deserves attention.?#TBM #MedDevice #HealthTech

The countdown is on for #LSIUSA25, kicking off on March 17 in Dana Point, California! We’re thrilled to be recognized as an innovator and to have the opportunity to present to investors and industry leaders in the #Medtech and #Healthtech communities. Ping us in the LSI app or here on Linked In to meet our team at the event. We look forward to collaborating with fellow innovators, investors, and strategics to drive meaningful advancements in healthcare, specifically in the treatment of #tracheobronchomalacia.

The following patient story is a perfect example of the many lives we aspire to impact as we continue our journey to make available a more effective way to improve and standardize airway restoration for better breathing. #meddevice #healthtech #tracheobronchomalacia

It's never too early to gear up for #LSIUSA25 which selected the most relevant innovators from around the globe to present in Dana Point, California, including Lazzaro Medical. Come see Dawn Bitz provide updates on our progress towards making a next generation treatment available for #tracheobronchomalacia. Reach out if you would like to meet with our team at the event in March.

Excited that our co-founder, Richard Lazzaro, MD FACS was invited by the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Leadership, to moderate the Tracheobronchomalacia - ISMICS Webinar this weekend. Panelists included a member of our medical advisory team, Dr. Sudish Murthy (Cleveland Clinic Foundation), Dr. Subin Lee (Rutgers), and Dr. David Abia-Trujillo (Mayo Clinic) sharing their experience in the evaluation and management of patients with #Tracheobronchomalacia Tracheobronchomalacia is often underdiagnosed, as its symptoms are frequently mistaken for COPD or asthma. However, acknowledging that Tracheobronchomalacia contributes to many patients’ symptoms underscores the need for a deeper understanding of its clinical presentation. This includes a thorough diagnostic work-up and collaborative, multidisciplinary decision-making to streamline the pathway to effective treatment. Robotic-Assisted Tracheobronchoplasty offers a surgical solution for airway stabilization, providing critical relief for affected patients. #roboticsurgery #tracheobronchoplasty

Honored to be recognized on this prestigious list, especially given the challenges of last year's funding environment. We're driven to keep pushing forward, enabling Lazzaro Medical to bring life-changing solutions to millions of people who deserve to breathe easily again. #meddevice #medicaldevice #tracheobronchomalacia

Tracheobronchomalacia (TBM) is a condition characterized by the weakening and collapse of the airway walls, leading to breathing difficulties and recurrent respiratory challenges. CureTBM Foundation is a non-profit with a mission to bring breaths to the breathless and raise awareness about the disease and advocate for patients. We want give them a shoutout during this time of giving and gratitude. #CureTBM